Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082). (Q48770246)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082). |
scientific article |
Statements
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082) (English)
Astrid Weyerbrock
1 reference
Thierry Gorlia
Martin J B Taphoorn
Jonathan Steuve
Marie-France Hamou
Antje Wick
Markus Kosch
Roger Stupp
Patrick Roth
Mario Campone
Damien Ricard
Christine Marosi
Salvador Villa
Kirsten Hopkins
Krisztian Homicsko
Benoit Lhermitte
Gianfranco Pesce
Wolfgang Wick